| Multiple sclerosis and cognition: synaptic failure and network dysfunction M Di Filippo, E Portaccio, A Mancini, P Calabresi Nature Reviews Neuroscience 19 (10), 599-609, 2018 | 197 | 2018 |
| Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis M Di Filippo, A De Iure, C Giampà, D Chiasserini, A Tozzi, PL Orvietani, ... Scientific reports 6 (1), 1-16, 2016 | 102 | 2016 |
| Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis M Di Filippo, A De Iure, C Giampà, D Chiasserini, A Tozzi, PL Orvietani, ... Scientific reports 6 (1), 1-16, 2016 | 102 | 2016 |
| Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis L Gaetani, N Salvadori, V Lisetti, P Eusebi, A Mancini, L Gentili, A Borrelli, ... Journal of Neurology 266, 2157-2163, 2019 | 55 | 2019 |
| CSF and blood biomarkers in neuroinflammatory and neurodegenerative diseases: implications for treatment L Gaetani, FP Paoletti, G Bellomo, A Mancini, S Simoni, M Di Filippo, ... Trends in pharmacological sciences 41 (12), 1023-1037, 2020 | 53 | 2020 |
| 2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes L Gaetani, L Prosperini, A Mancini, P Eusebi, MC Cerri, C Pozzilli, ... Journal of neurology 265, 2684-2687, 2018 | 52 | 2018 |
| Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis L Gaetani, M Di Carlo, G Brachelente, F Valletta, P Eusebi, A Mancini, ... Journal of neuroimmunology 339, 577108, 2020 | 43 | 2020 |
| Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson’s disease A Tozzi, M Tantucci, S Marchi, P Mazzocchetti, M Morari, P Pinton, ... Cell death & disease 9 (2), 204, 2018 | 43 | 2018 |
| Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis M Di Filippo, A De Iure, V Durante, L Gaetani, A Mancini, P Sarchielli, ... Brain research 1621, 205-213, 2015 | 39 | 2015 |
| Hippocampal neuroplasticity and inflammation: relevance for multiple sclerosis A Mancini, L Gaetani, M Di Gregorio, A Tozzi, V Ghiglieri, P Calabresi, ... Multiple Sclerosis and Demyelinating Disorders 2 (1), 1-12, 2017 | 38 | 2017 |
| Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis A Mancini, M Tantucci, P Mazzocchetti, A de Iure, V Durante, L Macchioni, ... Neurobiology of disease 113, 97-108, 2018 | 32 | 2018 |
| Hippocampal epileptogenesis in autoimmune encephalitis M Romoli, P Krashia, A Sen, D Franciotta, M Gastaldi, A Nobili, A Mancini, ... Annals of clinical and translational neurology 6 (11), 2261-2269, 2019 | 28 | 2019 |
| Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis L Gaetani, P Eusebi, A Mancini, L Gentili, A Borrelli, L Parnetti, ... Multiple sclerosis and related disorders 35, 228-232, 2019 | 26 | 2019 |
| Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease A Tozzi, V Durante, G Bastioli, P Mazzocchetti, S Novello, A Mechelli, ... Neurobiology of disease 118, 1-8, 2018 | 24 | 2018 |
| Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition P Mazzocchetti, A Mancini, M Sciaccaluga, A Megaro, L Bellingacci, ... Neurobiology of disease 140, 104848, 2020 | 22 | 2020 |
| Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis G Menculini, E Chipi, F Paolini Paoletti, L Gaetani, P Nigro, S Simoni, ... International Journal of Molecular Sciences 22 (9), 4440, 2021 | 21 | 2021 |
| Cerebrospinal fluid and serum d-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease T Nuzzo, M Miroballo, A Casamassa, A Mancini, L Gaetani, R Nisticò, ... Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1868 (12), 140537, 2020 | 20 | 2020 |
| Neuro-immune cross-talk in the striatum: from basal ganglia physiology to circuit dysfunction A Mancini, V Ghiglieri, L Parnetti, P Calabresi, M Di Filippo Frontiers in Immunology 12, 644294, 2021 | 17 | 2021 |
| From synaptic dysfunction to neuroprotective strategies in genetic Parkinson’s disease: lessons from LRRK2 A Mancini, P Mazzocchetti, M Sciaccaluga, A Megaro, L Bellingacci, ... Frontiers in Cellular Neuroscience 14, 158, 2020 | 17 | 2020 |
| High performance liquid chromatography determination of l-glutamate, l-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients … T Nuzzo, A Mancini, M Miroballo, A Casamassa, A Di Maio, G Donati, ... Amino acids 53, 435-449, 2021 | 16 | 2021 |
